Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

NCT07079150 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.

NCT NCT07079150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07079150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
January 31, 2032
Enrollment
1,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, hepatitis b virus (hbv), hepatitis b, chronic (chb)